196 related articles for article (PubMed ID: 25344216)
1. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
Zhang Z; Wang Q; Chen F; Liu J
Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.
Huang R; Huang D; Dai W; Yang F
Mol Cell Biochem; 2015 Jun; 404(1-2):251-7. PubMed ID: 25772486
[TBL] [Abstract][Full Text] [Related]
4. MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer.
Yuan K; Chen Z; Li W; Gao CE; Li G; Guo G; Yang Y; Ai Y; Wu L; Zhang M
Arch Med Res; 2015 Nov; 46(8):635-41. PubMed ID: 26656665
[TBL] [Abstract][Full Text] [Related]
5. CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.
Qian X; Song X; He Y; Yang Z; Sun T; Wang J; Zhu G; Xing W; You C
Biomed Pharmacother; 2015 Aug; 74():222-7. PubMed ID: 26349989
[TBL] [Abstract][Full Text] [Related]
6. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
Song GD; Sun Y; Shen H; Li W
Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
[TBL] [Abstract][Full Text] [Related]
7. HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report.
Saed L; Balcerczak E; Łochowski M; Olechnowicz E; Sałagacka-Kubiak A
Mol Genet Genomics; 2022 Nov; 297(6):1505-1514. PubMed ID: 35948739
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of FSCN1 in non-small cell lung cancer.
Luo A; Yin Y; Li X; Xu H; Mei Q; Feng D
Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
[TBL] [Abstract][Full Text] [Related]
10. HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer.
Jun KH; Jung JH; Choi HJ; Shin EY; Chin HM
Int J Surg; 2015 Dec; 24(Pt A):39-44. PubMed ID: 26537313
[TBL] [Abstract][Full Text] [Related]
11. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer.
Lin R; Shen W; Zhi Y; Zhou Z
Biomed Pharmacother; 2014 Oct; 68(8):929-34. PubMed ID: 25455159
[TBL] [Abstract][Full Text] [Related]
14. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer.
Wang YZ; Wu KP; Wu AB; Yang ZC; Li JM; Mo YL; Xu M; Wu B; Yang ZX
Tumour Biol; 2014 Oct; 35(10):9815-21. PubMed ID: 24986569
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of exosomal circPLK1 promotes the development of non-small cell lung cancer through the miR-1294/ high mobility group protein A1 axis.
Li C; Wang G; Ma X; Tao T; Li Q; Yang Y; Sang H; Wang Z
Bioengineered; 2022 Feb; 13(2):4185-4200. PubMed ID: 35114891
[TBL] [Abstract][Full Text] [Related]
17. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of
Palumbo Júnior A; de Sousa VPL; Esposito F; De Martino M; Forzati F; Moreira FCB; Simão TA; Nasciutti LE; Fusco A; Ribeiro Pinto LF; Bessa Pereira Chaves C; Meireles Da Costa N
Genes (Basel); 2019 May; 10(5):. PubMed ID: 31096664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
